Credo Diagnostics Biomedical
PrivateLast Round
Accelerator
Jul 16, 2020
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Credo Diagnostics Biomedical operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was an Accelerator round in July 2020.
Credo Diagnostics Biomedical is a medical technology company that develops, manufactures, and commercializes rapid and affordable point-of-care molecular diagnostic platforms for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Credo Diagnostics Biomedical Comparables
Compare Credo Diagnostics Biomedical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantuMDx | 87% | |
| Kryptos Biotechnologies, Inc. | 82% | |
| Autonomous Medical Devices Incorporated | 81% |
For institutional investors. Book with your work email.
Credo Diagnostics Biomedical Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Credo Diagnostics Biomedical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 301% MoM.
- Jan 22, 2026
Monthly visitors increased 683% MoM.
For institutional investors. Book with your work email.
Credo Diagnostics Biomedical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Credo Diagnostics Biomedical's valuation, stock price, and market status.
Is Credo Diagnostics Biomedical a public or private company?
Credo Diagnostics Biomedical is a private company.
What is the current stock price of Credo Diagnostics Biomedical?
Credo Diagnostics Biomedical is a private company, so its shares have no public market price. Caplight tracks Credo Diagnostics Biomedical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Credo Diagnostics Biomedical worth (valuation)?
Valuation information for Credo Diagnostics Biomedical is not publicly available.
Can I buy Credo Diagnostics Biomedical stock?
Credo Diagnostics Biomedical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Credo Diagnostics Biomedical's last funding round?
Credo Diagnostics Biomedical's most recent funding round was Accelerator on July 16, 2020.
Who are the main investors in Credo Diagnostics Biomedical?
Key investors in Credo Diagnostics Biomedical include MedTech Innovator.
Will Credo Diagnostics Biomedical IPO soon?
No public IPO plans have been announced for Credo Diagnostics Biomedical.
How can I track Credo Diagnostics Biomedical secondary market activity?
Caplight tracks bids, offers, and trades in Credo Diagnostics Biomedical's shares on secondary markets.